Novartis
NVS
#48
Rank
A$352.42 B
Marketcap
$173.66
Share price
-0.05%
Change (1 day)
14.51%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Total assets

Total assets on the balance sheet as of June 2024 : A$145.33 Billion

According to Novartis's latest financial reports the company's total assets are A$145.33 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novartis - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$146.69 B-15.01%
2022-12-31A$172.59 B-5.06%
2021-12-31A$181.79 B9.4%
2020-12-31A$166.17 B-1.71%
2019-12-31A$169.06 B-18.18%
2018-12-31A$206.62 B21.22%
2017-12-31A$170.46 B-5.57%
2016-12-31A$180.52 B-0.04%
2015-12-31A$180.58 B17.87%
2014-12-31A$153.21 B8.24%
2013-12-31A$141.54 B18.44%
2012-12-31A$119.50 B4.29%
2011-12-31A$114.59 B-5.61%
2010-12-31A$121.40 B14.19%
2009-12-31A$106.31 B-4.2%
2008-12-31A$110.98 B28.6%
2007-12-31A$86.30 B0.04%
2006-12-31A$86.27 B9.34%
2005-12-31A$78.90 B16.33%
2004-12-31A$67.82 B2.23%
2003-12-31A$66.34 B-16.98%
2002-12-31A$79.91 B1.19%
2001-12-31A$78.97 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
A$167.87 B 15.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$322.23 B 121.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$269.90 B 85.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$207.31 B 42.65%๐Ÿ‡ซ๐Ÿ‡ท France
A$109.50 B-24.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$61.61 B-57.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$141.06 B-2.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$108.83 B-25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$155.51 B 7.01%๐Ÿ‡ฌ๐Ÿ‡ง UK